Aktana

San Francisco, United States Founded: 2008 • Age: 18 yrs
AI-based engagement tools for pharmaceutical sales effectiveness are provided.
Annual revenue $1.1M Latest available
Total funding $90.7M 8 rounds
Employees 25 Tracked headcount
Investors 3 Known backers
Products 6 Services tracked
Competitors 9 Brand Intelligence

About Aktana

Aktana is a company based in San Francisco (United States) founded in 2008 by Jack O'Holleran and Derek Choy. Aktana has raised $90.7 million across 8 funding rounds from investors including Canadian Imperial Bank of Commerce, Safeguard Scientifics and Starfish Ventures. The company has 25 employees as of April 07, 2024. Aktana offers products and services including Aktana Platform, Strategy Orchestration, Field Orchestrator, Aktana Copilot, and Tactic Genie. Aktana operates in a competitive market with competitors including 6sense, Tact, Digital Pharmacist, EverString and Openprise, among others.

  • Headquarter San Francisco, United States
  • Employees 25 as on 07 Apr, 2024
  • Founders Jack O'Holleran, Derek Choy
  • Sectors
    Technology
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aktana India Private Limited
  • Date of Incorporation 11 Oct, 2021
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Technology → Enterprise Software & Productivity Solutions Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.12 M (USD)
    415.93
    as on Mar 31, 2023
  • Net Profit
    $119.35 K (USD)
    407.84
    as on Mar 31, 2023
  • EBITDA
    $175.09 K (USD)
    424.97
    as on Mar 31, 2023
  • Total Equity Funding
    $90.7 M (USD)

    in 8 rounds

  • Latest Funding Round
    $30 M (USD), Series D

    Oct 16, 2020

  • Investors
  • Employee Count
    25

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aktana

Aktana offers a comprehensive portfolio of products and services, including Aktana Platform, Strategy Orchestration, Field Orchestrator, Aktana Copilot, and Tactic Genie.

Product name locked
Category locked
Primary

Central platform for real-time strategy synchronization in pharma.

Product name locked
Category locked
Locked

Tools for planning and executing go-to-market strategies.

Product name locked
Category locked
Locked

Mobile app for real-time field activity recommendations.

Product name locked
Category locked
Locked

AI-driven insights for personalized field interactions.

Product name locked
Category locked
Locked

Automated intelligence for tactic generation and analysis.

Product name locked
Category locked
Locked

Platform for activating and amplifying engagement analytics.

People of Aktana

Headcount 200-500
Employee Profiles 32
Employee Profiles
People
John Vitalie
CEO
People
Kris Hinckley
VP, People
People
Pini Ben-Or
Chief Science Officer
People
Mark Desrosiers
Chief Revenue Officer (cro)

Unlock access to complete

Funding Insights of Aktana

Aktana has successfully raised a total of $90.7M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $30 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Aktana

Aktana has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, Safeguard Scientifics and Starfish Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Stage-agnostic sector-agnostic VC firm investing in Australia, New Zealand and the US
Locked Locked Locked
Venture capital firm investing in early and growth stage companies
Locked Locked Locked
Commercial banking services are provided to individuals and businesses.
Locked Locked Locked
Premium access

Investor details for Aktana

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aktana

Investments
Premium access

Investment portfolio details for Aktana

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aktana

Premium access

Detailed financials for Aktana

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aktana Comparisons

Aktana Primary company
Description
AI-based engagement tools for pharmaceutical sales effective...
Location
San Francisco, United States
Founded Year
2008
Annual Revenue
$1.12 M (USD)
Net Profit
$119.35 K (USD)
EBITDA
$175.09 K (USD)
Employees
25
As of 2024
Premium access

Peer comparison for Aktana

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aktana

Aktana operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 6sense, Tact, Digital Pharmacist, EverString and Openprise, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Predictive intelligence is delivered for sales and marketing teams.
Locked Locked Locked
AI-based customer engagement software for life science industries is provided.
Locked Locked Locked
Platform offering CRM software for pharmacies
Locked Locked Locked
Predictive analytics based sales and marketing platform
Locked Locked Locked
Data management and cleansing processes are automated through cloud platform.
Premium access

Detailed competitors of Aktana

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aktana

Premium access

Complete news archive for Aktana

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aktana

Aktana was founded in 2008 and raised its 1st funding round 3 years after it was founded.

Aktana is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

John Vitalie is the current CEO of Aktana.

Aktana is a funded company, having raised a total of $90.7M across 8 funding rounds to date.

As of Apr 07, 2024, the latest employee count at Aktana is 25.

Annual revenue of Aktana is $1.12M as on Mar 31, 2023.

Aktana was founded in 2008 in San Francisco, United States, as an AI-based tool for customer engagement in the pharmaceutical sector. Real-time insights, contextual data, and workflow guidance are delivered to sales representatives through integration with existing CRM systems. A Decision Support Engine is utilized to offer data-driven suggestions, fostering independent decision-making. Patterns in sales and marketing actions are analyzed to recommend strategy optimizations.

Aktana's top competitors include 6sense, Toplyne and Digital Pharmacist.

Aktana offers Aktana Platform, Strategy Orchestration, Field Orchestrator, Aktana Copilot, and 2 more products and services.

Aktana has 3 investors. Key investors include Canadian Imperial Bank of Commerce, Safeguard Scientifics, and Starfish Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available